Processing the protocol with id 141
##########################################
Searching for the item "2a Scientific background and explanation of rationale..."
This part was defined, probably, at this section: 1. Introduction
For more information about the rationales, go to sections:
1.5. Rationale for Study JMHD
For more information about the previous studies, go to sections:
1.4.2. Phase 2 Studies of Bevacizumab in Combination with 
1.4.3. Phase 2 Study of Bevacizumab in Combination with 
##########################################
Searching for the item "2b Specific objectives or hypotheses"...
This part was defined, probably, at this section: 2. Objectives
For more information about the primary objectives, go to sections:
2.1. Primary Objective
For more information about the secondary objectives, go to sections:
2.2. Secondary Objectives
Objectives: FOUND
Occurrences in the text:
53317	evaluate 	"...   to evaluate differences in patient reported outcomes (PROs), as assessed by the  Functional Assessment..."
52165	compare 	"... s to compare overall survival (OS) for:  Arm A: pemetrexed plus carboplatin plus bevacizumab, followed..."
52644	compare 	"...   to compare the overall response rates (RRs) and the disease control rates (DCRs),  assessed according..."
52856	compare 	"... s to compare the following time to event efficacy variables between the 2 treatment  arms:    ..."
53193	compare 	"... ) to compare hospitalizations, transfusions, and concomitant medication use  between the 2 treatment..."
53723	compare 	"...  and compare between the 2 treatment arms to characterize pemetrexed PK in patients randomized to Arm A...."
##########################################
Searching for the item "3a Description of trial design (such as parallel, factorial) including allocation ratio"...
This part was defined, probably, at this section: 3.1. Summary of Study Design
I found the following features of the study:
open label
randomized
1 of the following treatment arm
Phase 3
multicenter
Placebo: NOT FOUND -> active-controlled study?
Allocation ratio: 1:1, 1:1
##########################################
Checking for the item "4a Eligibility criteria for participants..."
This part was defined, probably, at this section: 4. Study Population
I have found: exclusion criteria, inclusion criteria
##########################################
Checking for the item "5 Interventions for each group with sufficient details to allow replication, including how and when they were actually administered"
This part was defined, probably, at this section: 5. Treatment
Maybe, these sections will be interested for you:
5.1. Treatments Administered
5.3. Method of Assignment to Treatment
5.5.1.5. Treatment Delays due to Insufficient Folic Acid or Vitamin B12 
5.8. Treatment Compliance
##########################################
Checking for the item “7a how sample size was determined”...
This part was defined, probably, at this section: 8. Sample Size and Statistical Methods
##########################################
Searching any information about a randomzation
This part was defined, probably, at this section: 5.3. Method of Assignment to Treatment
Maybe this information will be interesting:
51835	will be randomized	"... ntinued until disease progression (Arm B). In Study JMHD, patients with advanced, nonsquamous NSCLC will be randomized to receive  first line treatment for 4 cycles or until progression. Patients who..."
58883	will be randomized	"... are excluded  from Study JMHD. LY231514  H3E MC JMHD(f) Clinical Protocol Page 32 Eligible patients will be randomized in a 1:1 ratio to 1 of the following treatment arms:  Arm A Pemetrexed,..."
80948	will be randomized	"... to paclitaxel. 5.3. Method of Assignment to Treatment Patients who meet all criteria for enrollment will be randomized to Arm A or Arm B at the  baseline visit (Visit 0). Assignment to treatment..."
##########################################
Checking for the item “11a  if done, who was blinded after assignment to interventions (eg, participants, care providers, those assessing outcomes) and how.”
This part was defined, probably, at this section: 5.6. Blinding
##########################################
Checking for the item “12a  statistical methods used to compare groups for primary and secondary outcomes”
This part was defined, probably, at this section: 8. Sample Size and Statistical Methods
I found the following methods:
174027 	 logrank 	 "... s required in clinical trials using the logrank  test. Stat Med 1(2):121 129...."
154024 	 fisher  exact test 	 "... pared between Arm A and Arm B using the Fisher  exact test. 8.2.11. Subgroup..."
141518 	 kaplan meier 	 "...  a 2 sided significance level of 0.05). Kaplan Meier (K M) estimation (Kaplan ..."
142974 	 kaplan meier 	 "...  following analyses will be performed:  Kaplan Meier estimation, including..."
154506 	 kaplan meier 	 "... model. Then, subsequent log  rank test, Kaplan Meier estimate, and Cox..."
174579 	 fleming 	 "... col 19(3):843  850. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller,..."
143329 	 fisher exact test 	 "... pared between Arm A and Arm B using the Fisher exact test. A  95% confidence..."
155003 	 fisher exact test 	 "... eraction in the model. Then, subsequent Fisher exact test will be  performed to..."
155515 	 fisher exact test 	 "... raction in the model. Then, subsequent  Fisher exact test will be performed to..."
136174 	 log rank 	 "... mbination arm with the use of a 1 sided log rank test and a type I error of..."
141410 	 log rank 	 "... between Arm A and Arm B using a 1 sided log rank test at a significance level..."
143150 	 log rank 	 "... 3E MC JMHD(f) Clinical Protocol Page 72 log rank test    Cox regression model..."
162831 	 chi square 	 "...  cut point of the  population. The Wald chi square statistics for the..."
163166 	 chi square 	 "... mparison with the one degree of freedom chi square distribution  LY231514  H3E..."
163293 	 chi square 	 "... opriate. The probability of the maximum chi square value will be assessed using..."
179879 	 chi square 	 "... R, Siegmund D. 1982. Maximally selected chi square statistics. Biometrics..."
141760 	  cox  	 "... is of the primary outcome will include a Cox (1972) regression model to ..."
142372 	  cox  	 "... ude any cofactor (listed above) from the Cox models for 1 or more of the ..."
143166 	  cox  	 "... inical Protocol Page 72 log rank test    Cox regression model adjusting for the..."
154362 	  cox  	 "...  at the 0.10 level of significance using Cox regression model containing ..."
154532 	  cox  	 "... g  rank test, Kaplan Meier estimate, and Cox regression model will be performed..."
159727 	  cox  	 "...  corresponds  to the PFS HR 1.21 under a Cox PH model), then the trial would be..."
162644 	  cox  	 "... t in the  analytical model (for example, Cox regression of time to event..."
172021 	  cox  	 "...  serum creatinine.  Nephron 16(1):31 41. Cox DR. 1972. Regression models and..."
